Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F J Giles

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
Cancer|July 24, 2001
Mylotarg (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantationF J Giles, H M Kantarjian, S M Kornblau, et al.
Leukemia & Lymphoma|April 7, 2000
A prospective randomized study of alpha-2b interferon plus hydroxyurea or cytarabine for patients with early chronic phase chronic myelogenous leukemia: the International Oncology Study Group CML1 studyF J Giles, J Shan, S Chen, et al.
Hematology (Amsterdam, Netherlands)|July 14, 2016
Technetium-99m Sestamibi Scanning Reflects Marrow Activity in a β-Thalassemia Patient Treated with an Allogeneic Bone Marrow TransplantR M Look, H A Koh, S I Hamburg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemiaH M Kantarjian, S O'Brien, T L Smith, et al.
Leukemia|July 16, 2011
A phase Ib study of vosaroxin, an anticancer quinolone derivative, in patients with relapsed or refractory acute leukemiaJ E Lancet, F Ravandi, R M Ricklis, et al.
Leukemia|December 14, 2011
Nilotinib is effective in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blastic phaseF J Giles, H M Kantarjian, P D le Coutre, et al.
Leukemia|February 7, 2013
Phase Ia/II, two-arm, open-label, dose-escalation study of oral panobinostat administered via two dosing schedules in patients with advanced hematologic malignanciesD J DeAngelo, A Spencer, K N Bhalla, et al.
Blood Cancer Journal|February 4, 2017
Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromesR T Swords, J Watts, H P Erba, et al.
Leukemia|May 24, 2003
Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapyA-M Tsimberidou, H M Kantarjian, E Estey, et al.
Leukemia|March 6, 2013
Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinibT D Kim, D Rea, M Schwarz, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Cancer|July 24, 2001
Mylotarg (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantationF J Giles, H M Kantarjian, S M Kornblau, et al.
Leukemia & Lymphoma|April 7, 2000
A prospective randomized study of alpha-2b interferon plus hydroxyurea or cytarabine for patients with early chronic phase chronic myelogenous leukemia: the International Oncology Study Group CML1 studyF J Giles, J Shan, S Chen, et al.
Hematology (Amsterdam, Netherlands)|July 14, 2016
Technetium-99m Sestamibi Scanning Reflects Marrow Activity in a β-Thalassemia Patient Treated with an Allogeneic Bone Marrow TransplantR M Look, H A Koh, S I Hamburg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2000
Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemiaH M Kantarjian, S O'Brien, T L Smith, et al.
Leukemia|July 16, 2011
A phase Ib study of vosaroxin, an anticancer quinolone derivative, in patients with relapsed or refractory acute leukemiaJ E Lancet, F Ravandi, R M Ricklis, et al.
Leukemia|December 14, 2011
Nilotinib is effective in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blastic phaseF J Giles, H M Kantarjian, P D le Coutre, et al.
Leukemia|February 7, 2013
Phase Ia/II, two-arm, open-label, dose-escalation study of oral panobinostat administered via two dosing schedules in patients with advanced hematologic malignanciesD J DeAngelo, A Spencer, K N Bhalla, et al.
Blood Cancer Journal|February 4, 2017
Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromesR T Swords, J Watts, H P Erba, et al.
Leukemia|May 24, 2003
Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapyA-M Tsimberidou, H M Kantarjian, E Estey, et al.
Leukemia|March 6, 2013
Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinibT D Kim, D Rea, M Schwarz, et al.
Pageof 13